Where Deep Learning Ends
​Deep Thinking Begins.

---

Mind + Machine vs Disease

Oxford Immune Algorithmics (OIA) is a deep biotech company that builds upon and creates responsible Artificial Intelligence technology to develop a full-stack solution to remote health testing for cancer monitoring and clinical trials.

---

Medically-driven Remote Monitoring

Enabled by the synergy of human experts and super-human causal AI models, OIA helps healthcare professionals better monitor patients, reduce costs, and make decisions based on personalised profiles. 

---

Responsible AI for Healthcare Analytics

We enable health professionals and individuals to reach early diagnoses, help prevent conditions, and improve patient outcomes. We achieve this by rethinking how to exploit data and repurpose electronic components augmented by AI to develop cutting-edge monitoring technology.

---

CE Medical Devices Directive 93/42/EEC
& ​ISO 14971/DCB0129 Compliant

---

Algocyte® is OIA's flagship product. It helps health organisations complement their health monitoring strategies and shorten the life cycle of clinical trials.
​
Algocyte offers a set of tools to help medical professionals monitor their patients. We also help pharma and medical organisations shorten their full trial life cycle and reduce costs by minimising disruptive travelling to the clinic or the community.

---

Patents pending 1918950.5 and 1918948.9 (UK)

​With over two thousand members, our AI meetup groups in the UK are among the largest in their cities and demonstrate our commitment to connecting the academic and industrial communities and bring responsible AI to healthcare:

---

Reading

London

Oxford